| Literature DB >> 26272334 |
Daniel J Sobczynski1, Margaret B Fish1, Catherine A Fromen1, Mariana Carasco-Teja1, Rhima M Coleman2, Omolola Eniola-Adefeso1,2.
Abstract
Vascular wall endothelial cells control several physiological processes and are implicated in many diseases, making them an attractive candidate for drug targeting. Vascular-targeted drug carriers (VTCs) offer potential for reduced side effects and improved therapeutic efficacy, however, only limited therapeutic success has been achieved to date. This is perhaps due to complex interactions of VTCs with blood components, which dictate VTC transport and adhesion to endothelial cells. This review focuses on VTC interaction with blood as well as novel 'bio-inspired' designs to mimic and exploit features of blood in VTC development. Advanced approaches for enhancing VTCs are discussed along with applications in regenerative medicine, an area of massive potential growth and expansion of VTC utility in the near future.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26272334 PMCID： PMC4618056 DOI： 10.4155/TDE.15.38
Source DB: PubMed Journal: Ther Deliv ISSN： 2041-5990